Skip to content
GLP-1 Scorecard
Menu
Site position #317

NexLife

Published by GLP-1 ScorecardUpdated

NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).

Visit NexLifeWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$165/mo (compounded)
Tirzepatide
$215/mo (compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh NexLife against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value71/100
Dose & formulation64/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment67/100
Contract terms55/100

Strengths

  • LegitScript certified platform
  • Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
  • Both semaglutide and tirzepatide at competitive pricing
  • Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset

What to consider

  • State availability not publicly disclosed
  • Compounded only — no brand-name options
  • Also covers hormone optimization and longevity
  • Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
  • FDA issued Nexlife Inc. dba Nexlife a warning letter in June 2026; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Shoppers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1.

Site position #317 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to Nexlife Inc. dba Nexlife in June 2026. See the FDA warning-letter database.

Visit NexLife

Closest here

The rankings grading nearest NexLife — the realistic shortlist.

Curve#316

Curve (Try Curve LLC) is a telehealth platform offering compounded semaglutide and tirzepatide, prescribed by Beluga Health providers licensed in all 50 states and dispensed by VialsRx, a US 503A compounding pharmacy.

Sumbare Wellness#318

Langhorne, Pennsylvania telehealth platform selling compounded semaglutide, tirzepatide and a low-dose GLP-1 protocol on one flat $199/month plan, with the price confirmed only after a provider reviews you.

Transparent Meds#319

Transparent Meds is an online GLP-1 weight-care service that connects you with licensed medical providers and leads with upfront pricing: compounded weekly injections of semaglutide at an intro $149/month (reg $229) and tirzepatide at $249/month (reg $349), prescribed after a quiz and clinician review.

Immortals#320

Immortals offers a broad GLP-1 catalog, but three months paid in advance and a final-sale medicine policy make it a poor fit for shoppers seeking a one-month exit.

Peak Wellness#321

Telehealth wellness provider offering compounded GLP-1 medications with promotional first-month pricing.

TD Tele-Doc Weight Loss#322

TD Tele-Doc Weight Loss is a 100% virtual telehealth practice serving Virginia and Maryland that prescribes FDA-approved brand GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) and compounded semaglutide injections based on individual medical history and insurance coverage.

The 19 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect NexLife's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on NexLife's site. Not medical advice; see our disclosure.

← Back to the scorecard